COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2699: Articles 26981-26990  | Next

Pushing beyond specifications: Evaluation of linearity and clinical performance of a fully automated SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations
Nörz, D., Frontzek, A., Eigner, U., Oestereich, L., Fischer, N., Aepfelbacher, M., Pfefferle, S., Lütgehetmann, M.
10.1101/2020.05.28.20115469 — Posted: 2020-05-30
Predicting social distancing index during COVID-19 outbreak through online search engines trends
Lins Filho, P. C., Freitas, J. L. d. M., Araujo, M. M. S. d., Macedo, T. S. d., Ferreira, A. K. A., Melo, M. C. F. d., Silva, E. L. M. S. d., Caldas, A. d. F.
10.1101/2020.05.28.20115816 — Posted: 2020-05-30
Assessing the quality, readability and reliability of online information on COVID-19: aninfoveillance observational study
Lins Filho, P. C., Macedo, T. S. d., Ferreira, A. K. A., Melo, M. C. F. d., Araujo, M. M. S. d., Freitas, J. L. d. M., Caldas, T. U., Caldas, A. d. F.
10.1101/2020.05.30.20117614 — Posted: 2020-05-30
Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays
Lu, S., Paiva, K. J., Grisson, R. D., Chan, P. A., Lonks, J., King, E., Huard, R. C., Pytel-Parenteau, D. L., Nam, G. H., Yakirevich, E.
10.1101/2020.05.29.124776 — Posted: 2020-05-30
Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes
Hsieh, C.-L., Goldsmith, J. A., Schaub, J. M., DiVenere, A. M., Kuo, H.-C., Javanmardi, K., Le, K. C., Wrapp, D., Lee, A. G.-W., Liu, Y., Chou, C.-W., Byrne, P. O., Hjorth, C. K., Johnson, N. V., Ludes-Meyers, J., Nguyen, A. W., Park, J., Wang, N., Dzifa, A., Maynard, J. A., Finkelstein, I. J., McLellan, J. S.
10.1101/2020.05.30.125484 — Posted: 2020-05-30
A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots
Danh, K., Karp, D. G., Seftel, D., Robinson, P., Tsai, C.-t.
10.1101/2020.05.29.20116004 — Posted: 2020-05-30
Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease - a systematic review.
Nunes, J. P. L.
10.1101/2020.05.29.20116483 — Posted: 2020-05-30
COVID-3D: An online resource to explore the structural distribution of genetic variation in SARS-CoV-2 and its implication on therapeutic development
Portelli, S., Olshansky, M., Rodrigues, C. H. M., D'Souza, E. N., Myung, Y., Silk, M., Alavi, A., Pires, D. E. V., Ascher, D. B.
10.1101/2020.05.29.124610 — Posted: 2020-05-30
Analyzing Covid-19 Data using SIRD Models
Chakraborty, A., Chen, J., Desvars-Larrive, A., Klimek, P., Flores Tames, E., Garcia, D., Horstmeyer, L., Kaleta, M., Lasser, J., Reddish, J., Pinior, B., Wachs, J., Turchin, P.
10.1101/2020.05.28.20115527 — Posted: 2020-05-30
CoViD-19 in Italy: a mathematical model to analyze the epidemic containment strategy and the economic impacts
Verachi, F., Trussoni, L. G., Lanzi, L.
10.1101/2020.05.28.20115790 — Posted: 2020-05-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).